Intranasal desmopressin (Octim^TM): a safe and efficacious treatment option for children with bleeding disorders

Authors: KHAIR, K.; BAKER, K.; MATHIAS, M.; BURGESS, C.; LIESNER, R.

Source: Haemophilia, Volume 13, Number 5, September 2007 , pp. 548-551(4)

Buy & download fulltext article:

Price: $48.00 plus tax (Refund Policy)

Abstract:

Summary.

Desmopressin (1-deamino-8-D-arginine vasopressin (DDAVP)) has been shown to be an effective treatment option when administered both intravenously [ 1,2] and subcutaneously [ 3] to children with inherited bleeding disorders. We demostrate here, both the efficacy and acceptability of a new intranasal DDAVP preparation, providing a cost effective treatment with good outcomes for children with bleed disorders.

Keywords: DDAVP; desmopressin; children; bleeding; intranasal

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1365-2516.2007.01519.x

Publication date: 2007-09-01